VLP as Antigen
AP205
QBeta
5’-GTGG
AGATCT
T7 promoter
TAATACGACTCACTATAGGG
Qβ RNA hairpin (Qbeta pac signal)
AAATGCATGTCTAAGACAGCATCTTCGCG
targeting sequence
CAACATTCTGGGACACAAATTG
miR-30b GFP
CTGTGAAGCCACAGATGGG
targeting sequence complement
CAATTTGTGTCCCAGAATGTTG
TGC
T7 terminator
CTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
CTCGAG
GGTG-3
The native infectious Qβ virion displays 3–5 copies of a large (approximately 200 amino acids) domain extension at the C-terminus, termed the A1 protein, which is used to recognize the E. coli host
The number of incorporated extensions varied inversely with their length, from a minimum of 10 per particle for a modified version of the full-length A1 protein to a maximum of 81 per particle for extensions of 11–24 amino acids derived from the A1 sequence
Function, structure, and production of the most commonly used protein-based nanoparticles (PNPs).
| PNP | Native Organism | Biological Function | Geometry | Number of Subunits | Size (Diameter) | Heterologous Production | |
|---|---|---|---|---|---|---|---|
| Virus-like particles (VLPs) | |||||||
| CCMV 1 | Cowpea chlorotic mottle virus capsid protein | Plant virus |
Icosahedral | 182 | 28 nm | Plants; yeast; Escherichia coli; Pseudomonas fluorescens | |
| CPMV 2 | Cowpea mosaic virus capsid protein | Plant virus | Pseudo icosahedral | 120 Large (L) and 120 Small (S) | 28 nm | Insect cells; plants | |
| HBc 3 | Hepatitis B virus capsid protein | Human virus | Icosahedral | 180 or 240 | 30 nm or 34 nm | Mammalian cells; insect cells; plants; yeast; E. coli; cell-free | |
| MS2 | Enterobacteriaceae | Bacteriophage | Icosahedral | 180 | 26 nm | Yeast; E. coli; cell-free | |
| P22 | Salmonella typhimurium | Bacteriophage | Icosahedral | 420 | 60 nm | E. coli | |
| Qbeta | E. coli | Bacteriophage | Icosahedral | 180 | 28 nm | Yeast; E. coli; cell-free | |
| Non-viral PNPs | |||||||
| Dps 4(mini-ferritin) | Archaea; Bacteria (e.g., Listeria innocua) | Involved in oxidative and starvation responses | Tetrahedral | 12 | 9 nm | E. coli | |
| E2 | Bacillus stearothermophilus | Core of the pyruvate dehydrogenase multienzyme complex | Dodecahedral | 60 | 24 nm | E. coli | |
| Encapsulin | Archaea; Bacteria | Involved in oxidative stress response | Icosahedral | 60 or 180 | 20~40 nm | Mammalian cells; yeast; E. coli | |
| Ferritin (maxi-ferritin) | Archaea; Bacteria; Eukarya | Iron storage | Octahedral | 24 | 12 nm | Mammalian cells; insect cells; yeast; E. coli | |
| Hsp 5 | Archaea; Bacteria; Eukarya (e.g., Methanococcus jannaschii) | Chaperone | Octahedral | 24 | 12 nm | E. coli | |
| Lumazine synthase | Archaea; Bacteria; Eukarya (e.g., Aquifex aeolicus) | Mediates the biosynthesis of riboflavin | Icosahedral | 60 | 15.4 nm | E. coli | |
| Vault protein | Eukarya | Involved in signaling and immune responses | 39-fold dihedral | 78 Major vault protein | Diameter: 40 nm Length: 67 nm |
Insect cells; cell-free | |
1 Cowpea chlorotic mottle virus, 2 Cowpea mosaic virus, 3 Hepatitis virus, 4 DNA-binding proteins from starved cells, 5 Heat shock proteins.
Table 2. Methods used to bioengineer the most commonly used PNPs for a range of bioapplications.
| PNP | In Vitro Loading Mechanism | Cov Biocon 1 | Point Mut 2 | UAA 3 | Pep Disp 4 | Prot Disp 5 | Modul Assem 6 | Encapsulated Cargo | Applications | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diffusion 7 | In Vitro | In Vivo | ||||||||||
| VLPs | CCMV | pH; Ionic strength | * | * | * | * | Metals; small-molecule drugs; nucleic acids; organic polymers | Drug delivery; vaccines; bioimaging; prodrug activation; biocatalysis | ||||
| CPMV | * | * | * | * | Metals; fluorescent probes; biotin; organic polymers | Drug delivery; vaccines; bioimaging | ||||||
| HBc | Denaturants | * | * | * | * | * | * | Metals; small-molecule drugs; fluorescent probes; nucleic acids | Drug delivery; vaccines; bioimaging | |||
| MS2 | pH; Denaturants | * | * | * | * | * | Fluorescent probes; photosensitizers | Metals; small-molecule drugs; nucleic acids | Proteins | Drug delivery; vaccines; bioimaging; biocatalysis | ||
| P22 | pH | * | * | * | * | Metals; fluorescent probes; biotin; organometallic polymers | Proteins | Proteins; peptides; epitopes; nucleic acids | Drug delivery; vaccines; nanomaterial synthesis; biocatalysis; solubility enhancement | |||
| Qβ | pH; Denaturants | * | * | * | * | * | Fluorescent probes; cationic polymers | Metals; small-molecule drugs; fluorescent probes; nucleic acids | Proteins | Drug delivery; vaccines; bioimaging; nanomaterial synthesis | ||
Non-viral PNP |
Dps | * | * | * | Metals | Drug delivery; nanomaterial synthesis | ||||||
| E2 | Denaturants | * | * | * | * | * | Small-molecule drugs; fluorescent probes | Nucleic acids | Drug delivery; vaccines; biocatalysis; antibody purification | |||
| Encapsulin | pH; Denaturants | * | * | * | * | Metals | Proteins | Proteins | Drug delivery; bioimaging; immunotherapy; antimicrobials; biocatalysis | |||
| Ferritin | pH | * | * | * | * | * | Metals; small-molecule drugs | Bioactive compounds; metals; small-molecule drugs | Metals | Solubility enhancement; drug delivery; vaccines; bioimaging; immunotherapy; nanomaterial synthesis | ||
| Hsp | Temperature | * | * | * | * | Metals | Metals; small-molecule drugs; dyes; fluorescent probes | Drug delivery; nanomaterial synthesis; biocatalysis | ||||
| LS | Ionic strength | * | * | * | * | * | Proteins | Drug delivery; vaccines; bioimaging; biocatalysis | ||||
| Vault | “Breathing mechanism” | * | * | Metals; proteins; epitopes; antigens | Proteins | Solubility enhancement; drug delivery; vaccines; bioimaging; immunotherapy; bioremediation | ||||||
1 Covalent bioconjugation; 2 Point Mutation; 3 Unnatural amino acid incorporation; 4 Peptide display; 5 Whole protein display; 6 Modular assembly; 7 Pore-mediated diffusion
